| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Chen,Jin-An | Chairman | 23.81% | |
| Zion International Biomedical Investment INC. | Director | 6.85% | |
| Zhang,Zheng | Director | 0.11% | |
| Chen,Xi-An | Independent Director | 0.00% | |
| Yang,Zhi-Sheng | Independent Director | 0.00% | |
| Liu,Ying-Luan | Independent Director | 0.00% |
下載完整報告查看完整數據
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Operating income | - | 0 | 37 |
| Operating cost | - | 0 | 32 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | - | 0 | 5 |
| Unrealized profit (loss) on sales of goods | - | - | - |
| Realized profit (loss) on sales of goods | - | - | - |
| Operating gross profit (loss), net | - | 0 | 5 |
| Operating expenses | 17,739 | 27,246 | 34,424 |
| Other gain (loss), net | - | - | - |
| Operating profit (loss) | -17,739 | -27,246 | -34,419 |
| Non-operating income and expenses | 1,269 | 16,104 | 4,639 |
| Net profit (loss) before tax | -16,470 | -11,142 | -29,780 |
| Income tax expense (benefits) | -323 | -37 | -61 |
| Net profit (loss) of ongoing business for the current period | -16,147 | -11,105 | -29,719 |
| Profit (loss) of closed units | - | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | -16,147 | -11,105 | -29,719 |
| Other comprehensive profit (loss), net | 0 | -216 | -1,038 |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | -16,147 | -11,321 | -30,757 |
| Net profit (loss) attributable to owners of parent company | -16,147 | -11,104 | -29,717 |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Net profit (loss) attributable to non-controlling interests | 0 | -1 | -2 |
| Comprehensive profit (loss) attributable to owners of parent company | -16,147 | -11,320 | -30,755 |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | 0 | -1 | -2 |
| Basic earnings per share (yuan) | 0 | 0 | 0 |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | -32,873 | -23,565 | -38,057 |
| Net cash inflows (outflows) from investing activities | -16,041 | -57,875 | 7,134 |
| Net cash inflow (outflow) from financing activities | 4,767 | 129,847 | -26,394 |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | 85 | 927 | 668 |
| Increase (decrease) in cash and cash equivalents in the current period | -44,062 | 49,334 | -56,649 |
| Beginning balance of cash and cash equivalents | 59,000 | 9,666 | 66,315 |
| Ending balance of cash and cash equivalents | 14,938 | 59,000 | 9,666 |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current asset | 266,418 | 295,880 | 222,871 |
| Non-current asset | 98,170 | 87,506 | 83,659 |
| Total asset | 364,588 | 383,386 | 306,530 |
| Current liability | 60,129 | 65,666 | 49,024 |
| Non-current liability | 30,628 | 27,839 | 80,176 |
| Total liability | 90,757 | 93,505 | 129,200 |
| share capital | 426,189 | 426,189 | 344,889 |
| Equity - secruity token | - | - | - |
| capital reserve | 265,811 | 265,714 | 224,994 |
| retained earning | -418,169 | -402,022 | -390,918 |
| Other equity | 0 | 0 | -1,631 |
| Treasury stock | - | - | - |
| Total equity attributable to owners of parent company | 273,831 | 289,881 | 177,334 |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | 0 | 0 | -4 |
| Total Equity | 273,831 | 289,881 | 177,330 |
| Share capital awaiting retirement (unit: share) | - | - | - |
| Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
| Net asset value per share | 6 | 6 | 5 |
